{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:56:16Z","timestamp":1788411376591,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":1351,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK097948"],"award-info":[{"award-number":["DK097948"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK056762"],"award-info":[{"award-number":["DK056762"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI102269"],"award-info":[{"award-number":["AI102269"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK042191"],"award-info":[{"award-number":["DK042191"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK091222"],"award-info":[{"award-number":["DK091222"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK055812"],"award-info":[{"award-number":["DK055812"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RFA326877"],"award-info":[{"award-number":["RFA326877"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001063","name":"Crohn's and Colitis Foundation of America","doi-asserted-by":"publisher","award":["DK097948"],"award-info":[{"award-number":["DK097948"]}],"id":[{"id":"10.13039\/100001063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001063","name":"Crohn's and Colitis Foundation of America","doi-asserted-by":"publisher","award":["DK056762"],"award-info":[{"award-number":["DK056762"]}],"id":[{"id":"10.13039\/100001063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001063","name":"Crohn's and Colitis Foundation of America","doi-asserted-by":"publisher","award":["AI102269"],"award-info":[{"award-number":["AI102269"]}],"id":[{"id":"10.13039\/100001063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001063","name":"Crohn's and Colitis Foundation of America","doi-asserted-by":"publisher","award":["DK042191"],"award-info":[{"award-number":["DK042191"]}],"id":[{"id":"10.13039\/100001063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001063","name":"Crohn's and Colitis Foundation of America","doi-asserted-by":"publisher","award":["DK091222"],"award-info":[{"award-number":["DK091222"]}],"id":[{"id":"10.13039\/100001063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001063","name":"Crohn's and Colitis Foundation of America","doi-asserted-by":"publisher","award":["DK055812"],"award-info":[{"award-number":["DK055812"]}],"id":[{"id":"10.13039\/100001063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001063","name":"Crohn's and Colitis Foundation of America","doi-asserted-by":"publisher","award":["RFA326877"],"award-info":[{"award-number":["RFA326877"]}],"id":[{"id":"10.13039\/100001063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajp.amjpathol.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.ajpath.2015.11.028","type":"journal-article","created":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T18:38:13Z","timestamp":1456166293000},"page":"885-898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["IL-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis"],"prefix":"10.1016","volume":"186","author":[{"given":"Carlo","family":"De Salvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Pastorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Mattioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Omenetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine A.","family":"Buela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleem","family":"Chowdhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha R.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy A.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Rodriguez-Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek W.","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Cominelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgos","family":"Bamias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Vecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa T.","family":"Pizarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2015.11.028_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.ajpath.2015.11.028_bib2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.0606854104","article-title":"IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in\u00a0vivo","volume":"104","author":"Carriere","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2015.11.028_bib3","doi-asserted-by":"crossref","first-page":"8017","DOI":"10.1073\/pnas.0912678107","article-title":"Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1\/Th2 driven enteritis","volume":"107","author":"Pastorelli","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2015.11.028_bib4","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nature08900","article-title":"Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity","volume":"464","author":"Neill","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2015.11.028_bib5","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.4049\/jimmunol.181.7.4780","article-title":"IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4","volume":"181","author":"Kurowska-Stolarska","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2015.11.028_bib6","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1073\/pnas.0801898105","article-title":"IL-33 exacerbates antigen-induced arthritis by activating mast cells","volume":"105","author":"Xu","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2015.11.028_bib7","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/art.24305","article-title":"Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis","volume":"60","author":"Palmer","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2015.11.028_bib8","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.4049\/jimmunol.1000730","article-title":"IL-33 exacerbates eosinophil-mediated airway inflammation","volume":"185","author":"Stolarski","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2015.11.028_bib9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.1206587110","article-title":"IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms","volume":"110","author":"Hung","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2015.11.028_bib10","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1172\/JCI6560","article-title":"Fundamental signals that regulate eosinophil homing to the gastrointestinal tract","volume":"103","author":"Mishra","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2015.11.028_bib11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2222.2008.02958.x","article-title":"Eosinophils: biological properties and role in health and disease","volume":"38","author":"Hogan","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.ajpath.2015.11.028_bib12","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1136\/gut.2005.066423","article-title":"Eosinophil granulocytes are activated during the remission phase of ulcerative colitis","volume":"54","author":"Lampinen","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2015.11.028_bib13","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1189\/jlb.0807513","article-title":"Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis","volume":"84","author":"Lampinen","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ajpath.2015.11.028_bib14","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.4049\/jimmunol.181.10.7390","article-title":"Intestinal macrophage\/epithelial cell-derived CCL11\/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis","volume":"181","author":"Ahrens","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2015.11.028_bib15","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1189\/jlb.1212640","article-title":"CD14+CD33+ myeloid cell-CCL11-eosinophil signature in ulcerative colitis","volume":"94","author":"Lampinen","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ajpath.2015.11.028_bib16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.imlet.2009.11.001","article-title":"IL-33 is upregulated in colonocytes of ulcerative colitis","volume":"128","author":"Seidelin","year":"2010","journal-title":"Immunol Lett"},{"key":"10.1016\/j.ajpath.2015.11.028_bib17","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/ibd.21175","article-title":"Characterization of the novel ST2\/IL-33 system in patients with inflammatory bowel disease","volume":"16","author":"Beltran","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ajpath.2015.11.028_bib18","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00535-010-0245-1","article-title":"Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis","volume":"45","author":"Kobori","year":"2010","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.ajpath.2015.11.028_bib19","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.2353\/ajpath.2010.100378","article-title":"Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts","volume":"177","author":"Sponheim","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2015.11.028_bib20","doi-asserted-by":"crossref","first-page":"18581","DOI":"10.1073\/pnas.1003059107","article-title":"IL-33 is a crucial amplifier of innate rather than acquired immunity","volume":"107","author":"Oboki","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2015.11.028_bib21","first-page":"573","article-title":"Interleukin-33 suppresses Notch ligand expression and prevents goblet cell depletion in dextran sulfate sodium-induced colitis","volume":"28","author":"Imaeda","year":"2011","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.ajpath.2015.11.028_bib22","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/eji.201041135","article-title":"TGF-beta limits IL-33 production and promotes the resolution of colitis through regulation of macrophage function","volume":"41","author":"Rani","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ajpath.2015.11.028_bib23","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1136\/gutjnl-2011-301785","article-title":"Neutralisation of the interleukin-33\/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice","volume":"62","author":"Sedhom","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2015.11.028_bib24","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2119\/molmed.2011.00428","article-title":"Interleukin-33 ameliorates experimental colitis through promoting Th2\/Foxp3(+) regulatory T-cell responses in mice","volume":"18","author":"Duan","year":"2012","journal-title":"Mol Med"},{"key":"10.1016\/j.ajpath.2015.11.028_bib25","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/ibd.22900","article-title":"IL-33 attenuates development and perpetuation of chronic intestinal inflammation","volume":"18","author":"Gro\u00df","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ajpath.2015.11.028_bib26","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1002\/ibd.21638","article-title":"SAMP1\/YitFc mouse strain: a spontaneous model of Crohn's disease-like ileitis","volume":"17","author":"Pizarro","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ajpath.2015.11.028_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/gut.43.1.71","article-title":"Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1\/Yit strain","volume":"43","author":"Matsumoto","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2015.11.028_bib28","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1172\/JCI10956","article-title":"Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease","volume":"107","author":"Kosiewicz","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2015.11.028_bib29","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1053\/j.gastro.2004.11.053","article-title":"Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation","volume":"128","author":"Bamias","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2015.11.028_bib30","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cgh.2009.03.022","article-title":"A novel histologic scoring system to evaluate mucosal biopsies from patients with eosinophilic esophagitis","volume":"7","author":"Protheroe","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2015.11.028_bib31","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.4049\/jimmunol.178.3.1809","article-title":"Commensal bacteria exacerbate intestinal inflammation but are not essential for the development of murine ileitis","volume":"178","author":"Bamias","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2015.11.028_bib32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1084\/jem.190.4.487","article-title":"Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin a complexes","volume":"190","author":"Woerly","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2015.11.028_bib33","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.ajpath.2011.07.039","article-title":"CCR3 blockade attenuates eosinophilic ileitis and associated remodeling","volume":"179","author":"Masterson","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2015.11.028_bib34","first-page":"2429","article-title":"Eosinophils and IL-33 perpetuate chronic inflammation and fibrosis in a pediatric population with stricturing Crohn's ileitis","volume":"21","author":"Masterson","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ajpath.2015.11.028_bib35","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/eji.200324680","article-title":"Interleukin-5 participates in the pathogenesis of ileitis in SAMP1\/Yit mice","volume":"34","author":"Takedatsu","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ajpath.2015.11.028_bib36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1067\/mai.2003.139","article-title":"Chemokines in asthma: cooperative interaction between chemokines and IL-13","volume":"111","author":"Zimmermann","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ajpath.2015.11.028_bib37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1084\/jem.20050407","article-title":"The primary defect in experimental ileitis originates from a nonhematopoietic source","volume":"203","author":"Olson","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2015.11.028_bib38","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1053\/gast.2003.50148","article-title":"Emergence of perianal fistulizing disease in the SAMP1\/YitFc mouse, a spontaneous model of chronic ileitis","volume":"124","author":"Rivera-Nieves","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2015.11.028_bib39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nature12526","article-title":"Type 2 innate lymphoid cells control eosinophil homeostasis","volume":"502","author":"Nussbaum","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2015.11.028_bib40","doi-asserted-by":"crossref","first-page":"10762","DOI":"10.1073\/pnas.1509070112","article-title":"IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions","volume":"112","author":"Monticelli","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2015.11.028_bib41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaci.2015.05.037","article-title":"Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia","volume":"137","author":"Smith","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ajpath.2015.11.028_bib42","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/eji.201444969","article-title":"IL-33 activates eosinophils of visceral adipose tissue both directly and via innate lymphoid cells","volume":"45","author":"Hashiguchi","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ajpath.2015.11.028_bib43","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrgastro.2015.52","article-title":"The unusual suspects: innate lymphoid cells as novel therapeutic targets in IBD","volume":"12","author":"Goldberg","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2015.11.028_bib44","doi-asserted-by":"crossref","first-page":"e52332","DOI":"10.1371\/journal.pone.0052332","article-title":"IL-13 promotes collagen accumulation in Crohn's disease fibrosis by down-regulation of fibroblast MMP synthesis: a role for innate lymphoid cells?","volume":"7","author":"Bailey","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2015.11.028_bib45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","article-title":"Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis","volume":"39","author":"McHedlidze","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.ajpath.2015.11.028_bib46","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jaci.2014.05.011","article-title":"IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice","volume":"134","author":"Li","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ajpath.2015.11.028_bib47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/imm.12111","article-title":"Interleukin-33 exacerbates acute colitis via interleukin-4 in mice","volume":"140","author":"Pushparaj","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.ajpath.2015.11.028_bib48","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/eji.201343524","article-title":"Absence of a role for interleukin-13 in inflammatory bowel disease","volume":"44","author":"Biancheri","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ajpath.2015.11.028_bib49","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/gutjnl-2014-308337","article-title":"Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study","volume":"64","author":"Reinisch","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2015.11.028_bib50","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature13577","article-title":"The alarmin IL-33 promotes regulatory T-cell function in the intestine","volume":"513","author":"Schiering","year":"2014","journal-title":"Nature"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944016000742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944016000742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T23:48:40Z","timestamp":1617234520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944016000742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0002944016000742"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2015.11.028","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2015.11.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}